跳至主要内容
临床试验/NCT04429308
NCT04429308尚未招募2 期

PDT Versus the Combination of Jessner's Solution and 35% TCA for Treatment of Actinic Keratoses on Upper Extremities: A Randomized Controlled Split-arm Trial

Northwestern University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
尚未招募
入组人数
60
试验地点
2
主要终点
Percentage of total AKs cleared

研究概览

简要总结

The purpose of this study is to to compare photodynamic therapy (PDT) versus the combination of Jessner's solution and 35% trichloroacetic acid (TCA) chemical peels for the treatment of actinic keratoses on upper extremities.

This is a randomized clinical trial. Approximately 60 participants with actinic keratoses on both upper arms will be randomized to have one arm receive photodynamic therapy, while the contralateral arm receives Jessner's solution followed immediately by 35% TCA. AKs will be counted before treatment and 2-8 weeks after treatment. This study is a pilot study designed to determine the feasibility of this procedure.

Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • >18 years of age
  • Interested in receiving treatment for actinic keratoses on the bilateral upper arms
  • In good general health as assessed by the investigator
  • Participants must have the ability to understand and the willingness to sign a written informed consent prior to registration on study

排除标准

  • Patient pregnant or nursing
  • Patient with extensive concurrent skin conditions (such as eczema, psoriasis, etc) on upper extremities that would interfere with treatment as determined by the treating physician
  • Subject unwilling to sign an IRB approved consent form
  • Participants who are unable to communicate or cooperate with the investigator due to language problems, poor mental development, or impaired cerebral function are not eligible

研究组 & 干预措施

Chemical Peels

Active Comparator

One upper arm will be exposed to Jessner's Solution AND 35% Trichloroacetic acid peel

干预措施: Chemical Peels (Drug)

Photodynamic Therapy

Active Comparator

One upper arm will be exposed to blue light therapy

干预措施: Photodynamic Therapy (Procedure)

结局指标

主要结局

Percentage of total AKs cleared

时间窗: 2-8 weeks after treatments

Percentage of total AKs cleared will be calculated by counting the number of AKs before treatment and 2-8 weeks after treatments.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Murad Alam

Professor of Dermatology

Northwestern University

研究点 (2)

Loading locations...

相似试验

PDT vs Peels for Treatment of Actinic Keratoses | 临床试验